These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 26660536)

  • 1. Perinatal Lesioning and Lifelong Effects of the Noradrenergic Neurotoxin 6-Hydroxydopa.
    Kostrzewa RM
    Curr Top Behav Neurosci; 2016; 29():43-50. PubMed ID: 26660536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opiate-enhanced toxicity and noradrenergic sprouting in rats treated with 6-hydroxydopa.
    Harston CT; Clark MB; Hardin JC; Kostrzewa RM
    Eur J Pharmacol; 1981 May; 71(4):365-73. PubMed ID: 6788574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Destruction of catecholamine-containing neurons by 6-hydroxydopa, an endogenous amine oxidase cofactor.
    Kostrzewa RM; Brus R
    Amino Acids; 1998; 14(1-3):175-9. PubMed ID: 9871458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 6-hydroxydopa on noradrenergic neurons in developing rat brain.
    Kostrzewa RM; Garey RE
    J Pharmacol Exp Ther; 1976 Apr; 197(1):105-18. PubMed ID: 1263125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developmental localization of noradrenergic innervation to the rat cerebellum following neonatal 6-hydroxydopa and morphine treatment.
    Harston CT; Clark MB; Hardin JC; Kostrzewa RM
    Dev Neurosci; 1982; 5(2-3):252-62. PubMed ID: 6813097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of nerve cell bodies in caudal locus coeruleus following treatment of neonates with 6-hydroxydopa.
    Clark MB; King JC; Kostrzewa RM
    Neurosci Lett; 1979 Aug; 13(3):331-6. PubMed ID: 530483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in noradrenergic innervation of the brain following dorsal bundle lesions in neonatal rats.
    Klisans-Fuenmayor D; Harston CT; Kostrzewa RM
    Brain Res Bull; 1986 Jan; 16(1):47-54. PubMed ID: 3082466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of sprouting and putative regeneration of central noradrenergic fibers by morphine.
    Harston CT; Morrow A; Kostrzewa RM
    Brain Res Bull; 1980; 5(4):421-4. PubMed ID: 7407638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of systemic administration of 6-hydroxydopamine, 6-hydroxydopa and 1-methyl-4-phenyl-1,2,3,6-tetrahydroxypyridine (MPTP) on tuberoinfundibular dopaminergic neurons in the rat.
    Lin JY; Mai LM; Pan JT
    Brain Res; 1993 Oct; 624(1-2):126-30. PubMed ID: 8252384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of an opioid-specific action of morphine in modifying recovery of neonatally-damaged noradrenergic fibers in rat brain.
    Kostrzewa RM; Klisans-Fuenmayor D
    Res Commun Chem Pathol Pharmacol; 1984 Oct; 46(1):3-11. PubMed ID: 6438742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neonatal 6-hydroxydopa, but not DSP-4, elevates brainstem monoamines and impairs inhibitory avoidance learning in developing rats.
    Cornwell-Jones CA; Decker MW; Chang JW; Cole B; Goltz KM; Tran T; McGaugh JL
    Brain Res; 1989 Jul; 493(2):258-68. PubMed ID: 2504438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the mechanism of sprouting of noradrenergic terminals in rat and mouse cerebellum after neonatal 6-hydroxydopa.
    Kostrezewa RM; Klara JW; Robertson J; Walker LC
    Brain Res Bull; 1978; 3(5):525-31. PubMed ID: 122764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amygdalar noradrenergic and dopaminergic mechanisms in the regulation of hunger and thirst-motivated behavior.
    Lénárd L; Hahn Z
    Brain Res; 1982 Feb; 233(1):115-32. PubMed ID: 6800562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin conductance activity after intraventricular administration of 6-hydroxydopa in rats.
    Yamamoto K; Hoshino T; Takahashi Y; Kaneko H; Ozawa N
    Biol Psychiatry; 1991 Feb; 29(4):365-75. PubMed ID: 1903660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effect of various 6-hydroxydopa treatments on the development of central and peripheral noradrenergic neurons.
    Jaim-Etcheverry G; Zieher LM
    Eur J Pharmacol; 1977 Sep; 45(2):105-16. PubMed ID: 902684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of neurotoxins: from research modalities to clinical realities.
    Kostrzewa RM
    Curr Protoc Neurosci; 2009 Jan; Chapter 1():Unit 1.18. PubMed ID: 19170022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of central noradrenergic system in thyrotropin-releasing hormone-induced behavioral excitement in 6-OHDOPA-treated, infant rats.
    Oki K; Nomura Y; Segawa T
    J Pharmacobiodyn; 1982 Sep; 5(9):716-9. PubMed ID: 6818336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 6-hydroxydopamine and 6-hydroxydopa on development of behavior.
    Morgan DN; McLean JH; Kostrzewa RM
    Pharmacol Biochem Behav; 1979 Sep; 11(3):309-12. PubMed ID: 504311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of neonatal 6-hydroxydopa treatment on monamine content of rat brain and peripheral tissues.
    Kostrzewa RM
    Res Commun Chem Pathol Pharmacol; 1975 Aug; 11(4):567-79. PubMed ID: 1179028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catecholamine uptake inhibitors elevate 6-hydroxydopamine in brain after administration of 6-hydroxydopa.
    Evans J; Cohen G
    Eur J Pharmacol; 1993 Mar; 232(2-3):241-5. PubMed ID: 8467861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.